Pennsylvania’s recently enacted fiscal year 2025-26 state budget exemplifies the short-term political calculus that has plagued Pennsylvania for decades. After a historic 135-day impasse that ended on Nov. 12, 2025, Pennsylvania allocated merely $11.35 million for biotechnology research, a stark reduction from Governor Josh Shapiro’s proposed $50 million PA Innovation program. This dramatic 77% cut in life sciences funding is one of many reasons why Pennsylvania is losing to established biotech hubs like Massachusetts, North Carolina, and California, where multi-billion-dollar commitments and comprehensive ecosystem support have created self-sustaining innovation economies.
California, Massachusetts and North Carolina plan in decades and plant seeds for industries that will mature over generations. Conversely, Pennsylvania’s leaders continue satisfying immediate political constituencies at the expense of future prosperity. The result is a tragic pattern: Pennsylvania innovators and researchers pioneer transformative technologies, from the foundational architecture of the Internet at the University of Pennsylvania to the mRNA vaccine platform at the University of Pennsylvania, and then watch as these innovations commercialize elsewhere.
Result: Silicon Valley and Boston reap the economic harvests from seeds Pennsylvania plants but fails to cultivate.
Pennsylvania’s backward-looking orientation explains why Philadelphia, like Baltimore and Detroit, remains mired in post-industrial malaise while forward-thinking cities and states build 21st-century economies.
Consequence: The damage from today’s political expediency will be inherited by future generations of Pennsylvanians, who will ask why their state chose symbolic gestures over substantive investment when the window of opportunity was open.
Why Pennsylvania risks losing the biotech race
Pennsylvania’s pattern of short-term political expediency over long-term economic strategy is devastatingly consistent. Pennsylvania’s research institutions develop world-changing technologies, Pennsylvania’s political leaders celebrate these achievements with ribbon-cutting ceremonies and press releases, and then other states, those willing to think in decades rather than election cycles, build the industries and reap the economic rewards.
The Internet: The foundational architecture of the modern Internet emerged from research at the University of Pennsylvania in the 1940s and 1950s. ENIAC, the world’s first general-purpose electronic computer, was built at Penn in 1945. The university continued as a leader in computer science and networking research through subsequent decades. Yet when the commercial Internet exploded in the 1990s, Silicon Valley, not Pennsylvania, became synonymous with the digital revolution. California’s state and local governments had spent decades building the ecosystem: venture capital networks, risk-tolerant business culture, university-industry partnerships, and infrastructure investments. Pennsylvania had the research; California built the industry.
mRNA Vaccines: Dr. Katalin Karikó and Dr. Drew Weissman conducted their pioneering mRNA research at the University of Pennsylvania, work that would ultimately earn them the 2023 Nobel Prize in Physiology or Medicine. Their multi-decades long research at Penn laid the groundwork for the COVID-19 vaccines that saved millions of lives. Yet when mRNA technology commercialized, it was Massachusetts-based Moderna and Germany-based BioNTech (partnering with New York-based Pfizer) that reaped the economic rewards. Pennsylvania got the academic papers and few royalty dollars; Massachusetts got the $195 billion in Moderna’s peak market capitalization and thousands of high-paying jobs.
Pharmaceuticals: Pennsylvania once stood at the center of American pharmaceutical innovation. Merck, Smith Kline & French (now part of GSK), and Wyeth all had major Pennsylvania operations. But as the industry evolved toward biotechnology, other states made the strategic investments to capture the transition. Massachusetts launched its Life Sciences Initiative with $1 billion. North Carolina built NCBiotech. California leveraged its venture capital ecosystem. Pennsylvania watched its pharmaceutical companies relocate, consolidate, or stagnate.
Short-termism
Why does Pennsylvania repeatedly make this mistake? For the same reasons why donuts are more attractive than pushups. Allow me to explain:
Immediate Costs, Deferred Benefits: Life sciences investments require patient capital with decade-long time horizons. A $100 million annual investment in 2025 might not generate substantial returns until 2035 or 2040. Yet elections occur every two to four years. Politicians face intense pressure to demonstrate immediate results, such as a repaved road, a tax cut, expanded social services, rather than planting seeds that will mature after they’ve left office.
Visible Symbolism vs. Invisible Infrastructure: Cutting a ribbon at a new community center, delivering turkeys to low income families during Thanksgiving or announcing property tax relief generates immediate positive press coverage and voter gratitude. Building the invisible infrastructure of innovation ecosystems, such as talent pipelines, regulatory expertise, venture capital networks, specialized laboratory space, produces no comparable photo opportunities. The political return on investment heavily favors visible symbolism over substantive long-term strategy.
Concentrated Opposition, Diffuse Benefits: Every dollar invested in life sciences innovation is a dollar not spent elsewhere. Constituencies that might lose funding, such as social services, education, transportation, or other priorities, mobilize immediate opposition. The future beneficiaries of today’s investments, companies that don’t yet exist, workers not yet trained, tax revenues decades away, cannot advocate for themselves. This asymmetry biases political systems toward satisfying current constituencies at the expense of future prosperity.
The Virtue Signaling Trap: In an era of performative politics, elected officials gain more political benefit from symbolic gestures than substantive policy. Announcing a $50 million life sciences initiative generates the headline; quietly cutting it to $11.35 million in the final budget receives little attention. The virtue has been signaled, the political benefit captured, while the actual damage, stunted economic growth, lost opportunities, eroded competitiveness, won’t become apparent for years, long after current officeholders have moved on.
The inheritance: Post-industrial malaise
The consequences of this short-term orientation are visible across Pennsylvania’s landscape. Philadelphia, Pittsburgh, Erie, and Scranton all tell variations of the same story: industrial decline followed by decades of managed decline rather than genuine reinvention.
Philadelphia’s Paradox: Philadelphia hosts world-class research institutions — the University of Pennsylvania, Children’s Hospital of Philadelphia, Drexel University, Temple University, Thomas Jefferson University. The region’s life sciences sector employs over 70,000 people. Yet Philadelphia remains characterized by post-industrial decline: poverty rate above 20%, declining population, deteriorating public services, fiscal crisis. Why? Because Philadelphia’s political leadership remains oriented toward managing decline, negotiating public sector labor contracts, administering social services, maintaining decaying infrastructure, rather than building the future. The city superficially celebrates its universities’ research achievements but provides none of the substantive ecosystem support that would convert research into thriving companies and high-quality jobs.
The Detroit-Baltimore-Philadelphia Axis of Decline: Philadelphia increasingly resembles Baltimore and Detroit, great American cities whose leaders are mostly backward-looking, continuously relitigating the battles of previous generations rather than preparing for the economies of the next generation.
Detroit’s political leadership spent decades protecting the legacy automobile industry through tax abatements and subsidies while failing to invest in the electric vehicle, battery technology, and autonomous driving technologies that would define the industry’s future. When the transformation came, Detroit was unprepared, and the city collapsed into bankruptcy.
Read more review by Ajay Raju: Last longer than 30 seconds (
Baltimore’s political establishment remains fixated on distributional questions, such as which neighborhoods receive which services, which constituencies gain which benefits, while failing to address the structural question of economic growth. The city’s population has declined by over one-third since 1950. Political leaders focus on dividing a shrinking pie rather than baking a larger one.
Philadelphia follows the same pattern where 30 seagulls chase a single French Fry. Political discourse centers on tax rates, public sector labor relations, and social service distribution; essentially, how to manage decline. Forward-looking questions about economic transformation, innovation ecosystem development, and long-term competitiveness remain peripheral to political debate.
The contrast: States that think in decades
Massachusetts, North Carolina, and California demonstrate the alternative: states whose leaders understand that economic transformation requires patient, sustained investment over decades.
Massachusetts’ Fifty-Year Vision: Massachusetts did not become the nation’s leading biotech hub by accident. The state’s commitment began in the 1980s with investments in university research, regulatory streamlining, and strategic infrastructure. The 2008 Life Sciences Initiative represented not a beginning but an acceleration of a decades-long strategy. When that initial $1 billion commitment expired, Massachusetts reauthorized it — twice. In 2025, facing federal funding uncertainty, Massachusetts prepared its next reauthorization rather than retreating. This is governance oriented toward 2050, not 2026.
North Carolina’s Generational Patience: NCBiotech was established forty-one years ago in 1984. For four decades, through changing governors and legislative majorities, through boom and recession, North Carolina maintained its commitment. The payoff came gradually: a few companies in the 1990s, accelerating growth in the 2000s, and the $10+ billion investment surge in 2024. North Carolina’s leaders understood they were planting trees whose shade they might never sit under.
California’s Proposition 71 Model: When the George W. Bush administration restricted federal stem cell research funding in 2001, California could have accepted the federal decision. Instead, in 2004, California voters approved Proposition 71, a $3 billion bond measure creating the California Institute for Regenerative Medicine. This represented a conscious decision to think beyond immediate political constraints and invest in a technology that might not yield returns for decades. Twenty years later, that investment has helped maintain California’s life sciences leadership. Now, facing new federal cuts under the Trump administration, California is considering a $23 billion bond for 2026, once again thinking generationally.
The fertility of forward-thinking soil
Innovation flows to states that have spent decades creating fertile soil for industries of the future.
Talent Retention and Attraction: When a doctoral student at the University of Pennsylvania completes groundbreaking research, where does she pursue commercialization? If Pennsylvania offers no venture capital ecosystem, no established network of biotech entrepreneurs, no specialized laboratory space, and no state support programs, she relocates to Boston or San Francisco where that ecosystem exists. Massachusetts and California spent decades building these ecosystems while Pennsylvania held press conferences.
Capital Formation: Venture capital flows to ecosystems with demonstrated track records. Massachusetts’ decades of successful exits, specifically biotech companies going public or being acquired at premium valuations, attracted specialized life sciences investors. This capital density creates self-reinforcing advantages: more capital attracts more companies, more companies attract more capital. Pennsylvania never planted enough seeds for this virtuous cycle.
Specialized Infrastructure: Purpose-built laboratory space, biomanufacturing facilities, and innovation districts don’t appear overnight. They require long-term planning, zoning changes, infrastructure investments, and coordination between public and private sectors. Massachusetts identified life sciences as a strategic priority in the 1980s and began systematically building specialized infrastructure. Pennsylvania made no comparable commitment.
Institutional Knowledge: Over decades, Massachusetts has developed specialized expertise in every aspect of the life sciences ecosystem: lawyers who understand FDA regulatory pathways, investors who understand biotech business models, real estate developers who know how to build specialized facilities, government officials who can expedite permitting. This knowledge accumulates over decades and cannot be quickly replicated. Pennsylvania is decades behind in developing this institutional knowledge.
Intergenerational theft
The most damning aspect of Pennsylvania’s short-term orientation is its intergenerational injustice. Today’s political leaders make decisions that satisfy current voters and interest groups while imposing enormous costs on future generations who have no voice in current debates.
Stunted Human Capital: Pennsylvania high school students today who might pursue biotech careers will find limited opportunities in their home state. They will be forced to relocate to Massachusetts, North Carolina, or California to find career opportunities commensurate with their skills and ambitions. This brain drain compounds over decades, progressively weakening Pennsylvania’s competitive position.
Eroded Tax Base: The high-quality jobs that life sciences companies create, averaging $112,000 annually in North Carolina, represent not just employment but substantial tax revenue. Every company that locates in North Carolina rather than Pennsylvania, every talented scientist who moves to Boston rather than Philadelphia, represents lost tax revenue that future Pennsylvanians could have used for education, infrastructure, or public services.
Compounding Disadvantage: Ecosystem advantages compound over time. Massachusetts’ advantage today over Pennsylvania is greater than it was twenty years ago, which was greater than it was forty years ago. Every year Pennsylvania delays substantive investment, the gap widens, and catching up becomes more difficult. Current political leaders are not just failing to invest in the future; they are actively making the future more difficult for subsequent generations.
Inheritance of Decline: The children and grandchildren of current Pennsylvanians will inherit a state less competitive, less prosperous, and less dynamic than the state their parents and grandparents inherited, not because of inevitable economic forces but because of conscious political choices to prioritize short-term political expedience over long-term economic strategy.
The window is closing
Pennsylvania faces a narrowing window of opportunity. The state retains significant assets: world-class research universities, major hospital systems, pharmaceutical manufacturing infrastructure and expertise, and central East Coast location. But these advantages erode daily.
Every talented researcher who relocates, every innovative company that incorporates elsewhere, every investment dollar that flows to competing states makes Pennsylvania less competitive. Network effects in innovation ecosystems create winner-take-all dynamics: success attracts more success, and regions that fall behind face accelerating disadvantage.
Massachusetts understood this thirty years ago. North Carolina understood this forty years ago. California understood this fifty years ago. They made generational commitments and accepted short-term political costs in exchange for long-term economic transformation.
Pennsylvania’s political leaders continue behaving as though tomorrow will be like yesterday. This is how great states decline: not through dramatic collapse but through accumulated small failures of vision, courage, and intergenerational responsibility. Philadelphia, like Baltimore and Detroit before it, demonstrates what happens when political leadership remains oriented toward the past rather than the future, when virtue signaling substitutes for substantive strategy, when satisfying current constituencies takes absolute priority over building future prosperity.
The question is whether Pennsylvania will learn this lesson before the window of opportunity closes permanently. Governor Shapiro’s original $50 million proposal, while insufficient, represented recognition that Pennsylvania must compete. The actual $11.35 million allocation represents capitulation to the short-term political calculus that has plagued Pennsylvania for decades. Pennsylvania’s legislative leaders must recognize that competing with Massachusetts, North Carolina, and California requires not just matching their current investments but surpassing them to overcome Pennsylvania’s current disadvantages and decades of underinvestment.
The question is not whether Pennsylvania can afford to invest in life sciences innovation. The question is whether Pennsylvania can afford to continue its pattern of pioneering technologies that commercialize elsewhere, of celebrating research achievements that generate prosperity in other states, of imposing on future generations the costs of present political expediency.
The choice is binary: think in decades and build industries of the future or continue thinking in election cycles and manage inevitable decline. Future generations of Pennsylvanians will inherit the consequences of that choice.
1 Comment
Ajay, I always appreciate your comments when you are a guest on Channel 6 Your 40.000 ft view of the High tech subjest you commented on is well reasoned, The Problem I see is while you are looking at 40.00 ft we at ground zero, have a failed Philly school system that hands a High School diploma to our young people with #rd grade Reading and Math, Hence the reason why we are or were the Poorest Big City with 25% of our adults and 50% of our children, At or Below Poverty. We Won the Race to the Bottom because we forgot that in ordeer to take advantage of, and invest in, the kind of economic opportunities you speak of, we need to have our people qualified to benefit from those investments. Thank God for Med’s and Ed’s They are the only reason we are not Detroit or Canden IMHO Make Sense?